Department of Ophthalmology, University of Health Sciences, Beyoglu Eye Training and Research Hospital, Istanbul, Turkey.
Department of Ophthalmology, Dr. Ersin Arslan Training and Research Hospital, Gaziantep, Turkey.
Indian J Ophthalmol. 2023 Jan;71(1):174-179. doi: 10.4103/ijo.IJO_621_22.
To evaluate the efficacy and safety of posterior sub-Tenon triamcinolone (PSTA) in chronic postoperative cystoid macular edema (PCME) after pars plana vitrectomy (PPV).
Consecutive 22 patients who developed chronic PCME after PPV and underwent PSTA treatment were included in this retrospective study. Best-corrected visual acuity (BCVA) and central macular thickness (CMT) were measured pre injection and post injection at one month, three months, six months, and at last visit. The patients were divided into three groups according to the injection response status: complete, partial, and resistant.
The mean follow-up period was 26.4 ± 16.2 months after PSTA. According to pre-injection values, there was a significant improvement in the values of BCVA and CMT at the first, third, and sixth months and at the last examination (P < 0.05). In the final examination, PCME recovered completely in 12 patients, partially in 8 patients, and resistance was observed in 2 patients.
Posterior sub-Tenon triamcinolone seems to be effective in chronic PCME following PPV.
评估后Tenon 下曲安奈德（PSTA）治疗经睫状体平坦部玻璃体切割术（PPV）后慢性术后囊样黄斑水肿（PCME）的疗效和安全性。
本回顾性研究纳入了 22 例经 PPV 治疗后发生慢性 PCME 并接受 PSTA 治疗的患者。在注射前和注射后 1 个月、3 个月、6 个月和最后一次就诊时测量最佳矫正视力（BCVA）和中央黄斑厚度（CMT）。根据注射反应状态将患者分为三组：完全缓解、部分缓解和抵抗。
PSTA 后平均随访时间为 26.4 ± 16.2 个月。根据注射前的值，在第 1、3 和 6 个月以及最后一次检查时，BCVA 和 CMT 值均有显著改善（P < 0.05）。在最后一次检查时，12 例患者的 PCME 完全恢复，8 例患者部分恢复，2 例患者出现抵抗。
后Tenon 下曲安奈德似乎对 PPV 后慢性 PCME 有效。
Zotero 插件